Comment on

• Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

  Kadam RS, Kompella UB. Kadam RS, et al. J Pharmacol Exp Ther. 2010 Mar;332(3):1107-20. doi: 10.1124/jpet.109.161570. Epub 2009 Nov 19. J Pharmacol Exp Ther. 2010. Retraction in: J Pharmacol Exp Ther. 2015 Feb;352(2):326. doi: 10.1124/jpet.114.02er15. PMID: 19926800 Free PMC article. Retracted.
• Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

  Pfeifer T, Buchebner M, Chandak PG, Patankar J, Kratzer A, Obrowsky S, Rechberger GN, Kadam RS, Kompella UB, Kostner GM, Kratky D, Levak-Frank S. Pfeifer T, et al. Curr Pharm Biotechnol. 2011 Feb 1;12(2):285-92. doi: 10.2174/138920111794295774. Curr Pharm Biotechnol. 2011. PMID: 21190543 Free PMC article.
• Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

  Kadam RS, Cheruvu NP, Edelhauser HF, Kompella UB. Kadam RS, et al. Invest Ophthalmol Vis Sci. 2011 Jul 23;52(8):5387-99. doi: 10.1167/iovs.10-6233. Invest Ophthalmol Vis Sci. 2011. Retraction in: Invest Ophthalmol Vis Sci. 2015 Mar 09;56(3):1678. doi: 10.1167/iovs.10-6233a. PMID: 21282583 Free PMC article. Retracted.
• Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.

  Malik P, Kadam RS, Cheruvu NP, Kompella UB. Malik P, et al. Mol Pharm. 2012 Mar 5;9(3):605-14. doi: 10.1021/mp2005164. Epub 2012 Feb 8. Mol Pharm. 2012. Retraction in: Mol Pharm. 2015 Jul 6;12(7):2558. doi: 10.1021/acs.molpharmaceut.5b00366. PMID: 22256989 Free PMC article. Retracted.
• RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.

  Kadam RS, Tyagi P, Edelhauser HF, Kompella UB. Kadam RS, et al. Int J Pharm. 2012 Sep 15;434(1-2):140-7. doi: 10.1016/j.ijpharm.2012.05.025. Epub 2012 May 23. Int J Pharm. 2012. PMID: 22633904 Free PMC article.
• Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

  Kadam RS, Vooturi SK, Kompella UB. Kadam RS, et al. Drug Metab Dispos. 2013 Feb;41(2):466-74. doi: 10.1124/dmd.112.045674. Epub 2012 Nov 20. Drug Metab Dispos. 2013. Retraction in: Drug Metab Dispos. 2015 Feb;43(2):234. doi: 10.1124/dmd.114.045674err. PMID: 23169611 Free PMC article. Retracted.
• Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

  Kadam RS, Ramamoorthy P, LaFlamme DJ, McKinsey TA, Kompella UB. Kadam RS, et al. Mol Pharm. 2013 Jun 3;10(6):2350-61. doi: 10.1021/mp3007133. Epub 2013 May 22. Mol Pharm. 2013. Retraction in: Mol Pharm. 2015 Jul 6;12(7):2559. doi: 10.1021/acs.molpharmaceut.5b00367. PMID: 23607566 Free PMC article. Retracted.
• Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.

  Kadam RS, Williams J, Tyagi P, Edelhauser HF, Kompella UB. Kadam RS, et al. Mol Vis. 2013 May 30;19:1198-210. Print 2013. Mol Vis. 2013. Retraction in: Mol Vis. 2019 Feb 18;25:143. PMID: 23734089 Free PMC article. Retracted.
• Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor.

  Panda JJ, Yandrapu S, Kadam RS, Chauhan VS, Kompella UB. Panda JJ, et al. J Control Release. 2013 Dec 28;172(3):1151-60. doi: 10.1016/j.jconrel.2013.09.016. Epub 2013 Sep 25. J Control Release. 2013. Retraction in: J Control Release. 2016 Sep 10;237:186. doi: 10.1016/j.jconrel.2016.07.039. PMID: 24075925 Free PMC article. Retracted.